January 7, 2026 · Form 4 insider transaction
Ehrlich Christopher B bought 4,530,997 shares of CERo Therapeutics Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.